tofisopam has been researched along with Cognitive Decline in 1 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we investigated the potential therapeutic effects of tofisopam, a 2,3-benzodiazepine derivative anxiolytic, on cognitive deficits in rats with scopolamine-induced amnesia." | 3.96 | Antiamnesic effects of tofisopam against scopolamine-induced cognitive impairments in rats. ( Can, ÖD; Demir Özkay, Ü; Üçel, Uİ; Ulupinar, E, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Üçel, Uİ | 1 |
| Can, ÖD | 1 |
| Demir Özkay, Ü | 1 |
| Ulupinar, E | 1 |
1 other study available for tofisopam and Cognitive Decline
| Article | Year |
|---|---|
Antiamnesic effects of tofisopam against scopolamine-induced cognitive impairments in rats.
Topics: Amnesia; Animals; Avoidance Learning; Benzodiazepines; Cell Plasticity; Cell Proliferation; Cognitiv | 2020 |